Of course revenue is on everyone lips and we all like to see...

Of course revenue is on everyone lips and we all like to see progress in profit with customer placed orders since CGB reopened August last year with Costco and EPCO foods deals, with further prospects increase volumes this year with Costco Vitahemp oils and T12 mix blends, EPCO increase with food consumables and possible T12 hemps mix blends imports into Vietnam.

It seems the operational costs have go down this quarter and it appears were up from last quarter.

Its still early days and CGB outcomes with performances planning in 2020 as each division minimizing operational costs, securing more secured deals in delivering of raw stocks and completed product increase.

Each Division to have latest TGA licenses, Laos Asia, Sth Africa, Bio Health, in building layouts outfitted to completion in latest designed processing drying, sizing, extracting, decanting, filtering, and chromatography technology which will be assembled into a large capacity, in full production to increase volumes to produce revenue.

It will take time to synchronize all activities to meet all timelines, targeted based customers demand, coming to plan in one continuous flow to eventually accumulate revenue with a global plan to have global volume sales, manufacturing and distribution with importing and exporting in MM and raw hemp products, producing short term and long term revenue on a global scale.

Technion Haifa research and John Easterling cannabis formula XO 27 XP, and ONJ 18 XP and ONJ XO.

Both are innovating in developing MM formulas to assist multiple sclerosis and treating cancerous illness, and you need data in humans trails to prove MM formulas developments to better performance to know what you are looking at, to understand exactly what is happening.

It takes time and data as it evolves, creating something new, inventing new MM formulas making products better, safer, and faster producing MM formulas that other companies may not have, to distribution demand.

Its innovating where CGB is going with MM formulas with the likes of Prof Meiri, John Easterling, research is valuable, takes time, approvals, permits, with costs developments and monies...

Its innovating with AK seed bank producing High Grade food consumables and MM products in Laos Asia, five crops per year, indoor and outdoor with high possibilities in Cambodia and Thailand, including developments in Sth Africa producing hemp foods, MM products..

Skin care distrubtion in Australia, Asia with latest possible development in China in food consumables and skin care....awaiting on that outcome...

Canntab blister pack tablets, Cannabis Oil Gel Capsules to Asia and Australian market prior to sell hard tablet product

2020 is only just started, building outfits, latest design, technology, research, manufacturing will be part of operational costs with CGB performances planning as each division minimizing operational costs, securing more secured deals in delivering of raw stocks and completed product increase to produce revenue.

CGB are planning a long term strategy game, planning to be here for the long haul with having outstanding High Grade Quality MM formulas to global market distribution, High Grade food consumables, Hemp Oils, Skin care products, MM oils and tablet form.

best wishes to all CGB holders